Drugs & medicalClass II

Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC…

cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.

Read the official notice →
Date
2025-11-12
Country
United States
Brand
Zydus Pharmaceuticals
Product
clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC…
Classification
Class II
Units
Nationwide in the US
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Zydus Pharmaceuticals recalls

  1. 2026-01-28
  2. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed…

    Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

    FDA · DrugZydus Pharmaceuticals (USA) IncUS Nationwide.Official notice →
  3. 2026-01-07
  4. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India,…

    Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USAOfficial notice →
  5. 2025-11-26
  6. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd.,…

    Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USAOfficial notice →
  7. 2025-10-08
  8. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,…

    Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

    FDA · DrugZydus Pharmaceuticals (USA) IncDistributed Nationwide in the USAOfficial notice →
  9. 2025-09-24
  10. US
  11. 2025-09-17
  12. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi,…

    CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USAOfficial notice →
All 26 Zydus Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2025-11-12
  2. US
    Drugs & medicalClass I

    Integra LifeSciences Corp. (NeuroSciences) recalls CODMAN Disposable Perforator 11mm. Cranial Perforator.

    Expansion of recall of size 14 mm Codman Disposable Perforators for inadequate welds to size 11 mm and 9 mm Codman Disposable Perforators out of an abundance of caution.

    FDA · DeviceIntegra LifeSciences Corp. (NeuroSciences)Worldwide distribution - US Nationwide and the countries of Argentina,…Official notice →
  3. US
    Drugs & medicalClass II

    OSSTEM Implant Co., Ltd. recalls Osstem Dental X-Ray System T2. Product Model Numbers T2-C and T2-CS.

    Osstem Implant Co. Ltd, is voluntarily initiating a medical device correction involving the current labeling for this electronic product may be missing a required Certification Statement under 21 CFR Subchapter J…

    FDA · DeviceOSSTEM Implant Co., Ltd.U.S.Official notice →
  4. US
    Drugs & medicalClass II

    Aero Healthcare recalls Acetaminophen 500mg Caffeine 65mg caplets, packaged as 2 caplets per packet further packaged in a 50-count box, AERO TAB, Manufactured for…

    Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin…

    FDA · DrugAero HealthcareUS Nationwide.Official notice →
  5. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only,…

    Subpotent drug; Clavulanate Potassium component

    FDA · DrugTeva Pharmaceuticals USA, IncDistributed in three (3) States: MS, OH, CA.Official notice →
  6. 2025-11-05
  7. US
    Drugs & medicalClass II

    Microgenics Corporation recalls Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac Control, Model/Catalog Number: OCRD-L, OCRD-101, OCRD-202, OCRD-303,…

    The firm received complaints from customers reporting vial-to-vial variability when using the control with high sensitivity Troponin I assays. This defect may lead to as delay in patient results for hs Troponin I assays.

    FDA · DeviceMicrogenics CorporationWorldwide - US Nationwide distribution in the states of AL, OK, NH, NY, WI,…Official notice →
  8. US
    Drugs & medicalClass II

    Cepheid recalls Xpert SA Nasal Complete Catalog Number: GXSACOMP-10 UDI-DI code: 07332940000158 Xpert SA Nasal Complete kit; 10 test kit: A collection of…

    As a result of Post-Market half-time stability testing, false negative test result was observed for a positive sample type.

    FDA · DeviceCepheidU.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA,…Official notice →
See all drugs & medical recalls →